Shangquan Liu
- Pharmacology top 5%
- Berberine and alkaloids research 1
- Pharmacology top 10%
- Berberine and alkaloids research 1
-
- Diet, Metabolism, and Disease 1
-
- Ginseng Biological Effects and Applications 1
-
- Cancer-related molecular mechanisms research 1
-
- Lipid metabolism and disorders 1
-
- CAR-T cell therapy research 1
- Cancer Immunotherapy and Biomarkers 1
-
- Immunotherapy and Immune Responses 1
- Partner nations
- China
In The Last Decade
Shangquan Liu
5 papers receiving 348 citations
Peers
Comparison fields: 5 of 59
- Pharmacology 125
- Pharmacology 126
- Endocrinology, Diabetes and Metabolism 60
- Biochemistry 19
- Molecular Biology 208
Countries citing papers authored by Shangquan Liu
This map shows the geographic impact of Shangquan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shangquan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shangquan Liu more than expected).
Fields of papers citing papers by Shangquan Liu
This network shows the impact of papers produced by Shangquan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shangquan Liu. The network helps show where Shangquan Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shangquan Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 24 | |
| 2 | 2020 | 4 | |
| 3 | 2009 | 57 | |
| 4 | 2007 | 156 | |
| 5 | 2006 | 119 |
About Shangquan Liu
Shangquan Liu is a scholar working on Cancer Research, Pharmacology and Oncology, having authored 5 papers that have together received 360 indexed citations. Recurring topics across this work include Berberine and alkaloids research (1 paper), Ginseng Biological Effects and Applications (1 paper), Cancer-related molecular mechanisms research (1 paper), Diet, Metabolism, and Disease (1 paper), Lipid metabolism and disorders (1 paper), CAR-T cell therapy research (1 paper), Cancer Immunotherapy and Biomarkers (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Pharmacology (125 citations), Pharmacology (126 citations) and Endocrinology, Diabetes and Metabolism (60 citations). Shangquan Liu has collaborated with scholars based in China. Frequent co-authors include Libin Zhou, Wenbin Shang, Ming‐Dao Chen, Ying Yang, Boren Jiang, Hua Jin, Guoyue Yuan, Fengying Li, Jinfeng Tang and Jialun Chen. Their work appears in journals such as Life Sciences, Metabolism and Fitoterapia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.